-
EP0742793
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0742793
| EP0742793 - BCL-2-ASSOCIATED PROTEINS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.03.2005 Database last updated on 31.08.2024 | Most recent event Tooltip | 11.03.2005 | Application deemed to be withdrawn | published on 27.04.2005 [2005/17] | Applicant(s) | For all designated states LA JOLLA CANCER RESEARCH FOUNDATION 10901 North Torrey Pines Road La Jolla, CA 92037 / US | [1996/47] | Inventor(s) | 01 /
REED, John, C. 4375 Tuolomne Place Carlsbad, CA 92008 / US | 02 /
TAKAYAMA, Shinichi 7548 Charmant Drive 1428 San Diego, CA 92122 / US | 03 /
SATO, Takaaki 5240 Fiore Terrace 211 San Diego, CA 92122 / US | [1996/47] | Representative(s) | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB Beselerstrasse 4 22607 Hamburg / DE | [N/P] |
| Former [1996/47] | UEXKÜLL & STOLBERG Patentanwälte Beselerstrasse 4 22607 Hamburg / DE | Application number, filing date | 95902489.4 | 09.11.1994 | [1996/47] | WO1994US12904 | Priority number, date | US19930152485 | 12.11.1993 Original published format: US 152485 | [1996/47] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9513292 | Date: | 18.05.1995 | Language: | EN | [1995/21] | Type: | A1 Application with search report | No.: | EP0742793 | Date: | 20.11.1996 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.05.1995 takes the place of the publication of the European patent application. | [1996/47] | Search report(s) | International search report - published on: | US | 18.05.1995 | (Supplementary) European search report - dispatched on: | EP | 19.06.1998 | Classification | IPC: | C07K14/47, C12N15/11, C12N15/63, C12N15/85, C07H21/00 | [1996/47] | CPC: |
C07K16/18 (EP,US);
C07K14/47 (EP,US);
C07K14/82 (EP,US);
A61K38/00 (EP,US);
C07K2319/00 (EP,US);
C12N2799/026 (EP,US)
| Designated contracting states | CH, DE, FR, GB, IT, LI, NL [1996/47] | Title | German: | Mit BCL - 2 Assoziiertes Protein | [1996/47] | English: | BCL-2-ASSOCIATED PROTEINS | [1996/47] | French: | PROTEINES ASSOCIEES A LA BCL-2 | [1996/47] | Entry into regional phase | 05.06.1996 | National basic fee paid | 05.06.1996 | Search fee paid | 05.06.1996 | Designation fee(s) paid | 05.06.1996 | Examination fee paid | Examination procedure | 12.06.1995 | Request for preliminary examination filed | 05.06.1996 | Examination requested [1996/47] | 17.07.2001 | Despatch of a communication from the examining division (Time limit: M06) | 27.02.2002 | Reply to a communication from the examining division | 13.05.2003 | Despatch of a communication from the examining division (Time limit: M06) | 15.10.2003 | Reply to a communication from the examining division | 06.11.2003 | Despatch of a communication from the examining division (Time limit: M04) | 10.03.2004 | Reply to a communication from the examining division | 14.06.2004 | Communication of intention to grant the patent | 26.10.2004 | Application deemed to be withdrawn, date of legal effect [2005/17] | 26.11.2004 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2005/17] | Request for further processing for: | 27.02.2002 | Request for further processing filed | 27.02.2002 | Full payment received (date of receipt of payment) Request granted | 25.03.2002 | Decision despatched | Fees paid | Renewal fee | 11.11.1996 | Renewal fee patent year 03 | 10.11.1997 | Renewal fee patent year 04 | 10.11.1998 | Renewal fee patent year 05 | 12.11.1999 | Renewal fee patent year 06 | 13.11.2000 | Renewal fee patent year 07 | 14.11.2001 | Renewal fee patent year 08 | 13.11.2002 | Renewal fee patent year 09 | 12.11.2003 | Renewal fee patent year 10 | Penalty fee | Additional fee for renewal fee | 30.11.2004 | 11 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO9320200 (IMP CANCER RES TECH [GB], et al) [Y] 22,25,28,32,35* figure 9; claims 1-33 *; | [XY] - FERNANDEZ-SARABIA MJ ET AL, "Bcl-2 associates with the ras-related protein R-ras p23.", NATURE, NOV 18 1993, 366 (6452) P274-5, ENGLAND, XP002053554 [X] 10-13,19 * the whole document * [Y] 22,25,28,32,35 DOI: http://dx.doi.org/10.1038/366274a0 | International search | [X] - CELL, Volume 74, issued 27 August 1993, Z.N. OLTVAI et al., "Bcl-2 Heterodimerizes In Vivo with a Conserved Homolog, Bax, that Accelerates Programmed Cell Death", pages 609-619. | [A] - SCIENCE, Volume 258, issued 09 October 1992, I. GARCIA et al., "Prevention of Programmed Cell Death of Sympathetic Neurons by the bcl-2 Proto-Oncogene", pages 302-304. | [A] - NATURE, Volume 359, issued 08 October 1992, R.P. BISSONNETTE et al., "Apoptotic Cell Death Induced by c-myc is Inhibited by bcl-2", pages 552-554. | [A] - JOURNAL OF IMMUNOLOGY, Volume 144, No. 9, issued 01 May 1990, G. NUNEZ et al., "Deregulated Bcl-2 Gene Expression Selectively Prolongs Survival of Growth Factor-Deprived Hemopoietic Cell Lines", pages 3602-3610. |